• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血再灌注对慢性肠系膜缺血开放肠系膜旁路术后结局的影响。

Effect of ischemia-reperfusion on outcomes after open mesenteric bypass for chronic mesenteric ischemia.

作者信息

Crawford Jeffrey D, Scali Salvatore T, Khan Tabassum, Back Martin R, Cooper Michol, Arnaoutakis Dean K, Berceli Scott A, Upchurch Gilbert J, Huber Thomas S, Giles Kristina A

机构信息

Division of Vascular Surgery and Endovascular Therapy, University of Florida College of Medicine, Gainesville, Fla.

Division of Vascular Surgery and Endovascular Therapy, University of Florida College of Medicine, Gainesville, Fla.

出版信息

J Vasc Surg. 2021 Oct;74(4):1301-1308.e1. doi: 10.1016/j.jvs.2021.03.039. Epub 2021 Apr 19.

DOI:10.1016/j.jvs.2021.03.039
PMID:33887424
Abstract

OBJECTIVE

Significant physiologic perturbations can occur in patients with chronic mesenteric ischemia (CMI) undergoing open mesenteric bypass (OMB). These events have frequently been attributed to ischemia-reperfusion events and have been directly implicated in the occurrence of multiple organ dysfunction (MOD). Scoring systems (MOD score [MODS] and sequential organ failure assessment [SOFA]) have been derived within the critical care field to provide a composite metric for these pathophysiologic changes. The purpose of the present study was to describe the early pathophysiologic changes that occur after OMB for CMI and determine whether these are predictive of the outcomes.

METHODS

Patients with CMI who had undergone elective OMB from 2002 to 2018 at a single institution were reviewed. Changes in the hemodynamic, pulmonary, hepatic, renal, and hematologic parameters in the first 96 hours postoperatively were analyzed. The MODSs and SOFA scores were calculated. Cox regression was used to determine the association of the MODSs and SOFA scores with the outcomes.

RESULTS

The use of OMB was analyzed for 72 patients (age, 66 ± 11 years; 68% women; body mass index, 23.8 ± 6 kg/m; 48 ± 34-lb weight loss in 59%). Previous mesenteric stent placement or bypass had been performed in 39% [stenting in 21; bypass in 8; (one patient had both)]. An antegrade configuration (93%) was most common (retrograde configuration, 7%), with revascularization of the superior mesenteric artery/celiac vessels in 85% (superior mesenteric artery only in 15%). Postoperative pathophysiologic and metabolic changes were common, and the mean MODSs and SOFA scores were 3.6 ± 2.4 (range, 1-10) and 4.0 ± 2.7 (range, 1-13), respectively. The median length of stay was 14 days (interquartile range, 9-21). The 30-day mortality was 4% (n = 3) and in-hospital morbidity was 53% (n = 38; gastrointestinal, 25%; infectious, 22%; cardiac, 18%; pulmonary, 18%; renal, 11%). The clinical follow-up period was 16 ± 20 months. The MODSs and SOFA scores correlated linearly with overall mortality (MODS: odds ratio [OR], 1.4; 95% confidence interval [CI], 1.2-1.7; P < .01; SOFA score: OR, 1.4; 95% CI, 1.2-1.7; P < .01 per unit), with a score of ≥5 the inflection point most predictive of mortality (MODS: OR, 3.9; 95% CI, 1.6-9.9; P ≤ .01; SOFA score: OR, 2.8; 95% CI, 1.2-6.6; P = .02). The 1- and 3-year primary bypass patency and freedom from reintervention was 91% ± 5% and 83% ± 7%, respectively, with no association with the MODSs or SOFA scores. The 1- and 3-year survival was 86% ± 4% and 71% ± 6% with significantly worse outcomes for patients with higher MODSs and/or SOFA scores.

CONCLUSIONS

Most CMI patients undergoing OMB will experience significant metabolic derangements resulting from sequelae of the ischemia-reperfusion phenomenon postoperatively. These can be objectively assessed in the early postoperative period using simply applied scoring systems to reliably predict the early and long-term outcomes. A derivation of the MODS and/or SOFA score after OMB for CMI can identify the most vulnerable patients at the greatest risk of mortality.

摘要

目的

接受开放性肠系膜旁路手术(OMB)的慢性肠系膜缺血(CMI)患者可能会出现显著的生理紊乱。这些事件常被归因于缺血再灌注事件,并直接与多器官功能障碍(MOD)的发生相关。重症监护领域已得出评分系统(MOD评分[MODS]和序贯器官衰竭评估[SOFA]),以提供这些病理生理变化的综合指标。本研究的目的是描述CMI患者接受OMB后早期发生的病理生理变化,并确定这些变化是否可预测预后。

方法

回顾了2002年至2018年在单一机构接受择期OMB的CMI患者。分析术后前96小时内的血流动力学、肺、肝、肾和血液学参数变化。计算MODS和SOFA评分。采用Cox回归确定MODS和SOFA评分与预后的关联。

结果

对72例患者(年龄66±11岁;68%为女性;体重指数23.8±6kg/m²;59%体重减轻48±34磅)的OMB使用情况进行了分析。39%的患者曾进行过肠系膜支架置入或旁路手术(21例置入支架;8例进行过旁路手术;1例两者均有)。顺行构型(93%)最为常见(逆行构型7%),85%的患者肠系膜上动脉/腹腔血管进行了血运重建(仅肠系膜上动脉血运重建15%)。术后病理生理和代谢变化常见,MODS和SOFA评分的平均值分别为3.6±2.4(范围1 - 10)和4.0±2.7(范围1 - 13)。中位住院时间为14天(四分位间距9 - 21天)。30天死亡率为4%(n = 3),住院发病率为53%(n = 38;胃肠道25%;感染22%;心脏18%;肺18%;肾11%)。临床随访期为16±20个月。MODS和SOFA评分与总死亡率呈线性相关(MODS:比值比[OR],1.4;95%置信区间[CI],1.2 - 1.7;P <.01;SOFA评分:OR,1.4;95% CI,1.2 - 1.7;每单位P <.01),评分≥5是最能预测死亡率的转折点(MODS:OR,3.9;95% CI,1.6 - 9.9;P≤.01;SOFA评分:OR,2.8;95% CI,1.2 - 6.6;P =.02)。1年和3年的初次旁路通畅率和无需再次干预率分别为91%±5%和83%±7%,与MODS或SOFA评分无关。1年和3年生存率分别为86%±4%和71%±6%,MODS和/或SOFA评分较高的患者预后明显较差。

结论

大多数接受OMB的CMI患者术后会因缺血再灌注现象的后遗症而出现显著的代谢紊乱。术后早期可使用简单应用的评分系统对这些情况进行客观评估,以可靠地预测早期和长期预后。CMI患者接受OMB后得出的MODS和/或SOFA评分可识别出死亡风险最高的最脆弱患者。

相似文献

1
Effect of ischemia-reperfusion on outcomes after open mesenteric bypass for chronic mesenteric ischemia.缺血再灌注对慢性肠系膜缺血开放肠系膜旁路术后结局的影响。
J Vasc Surg. 2021 Oct;74(4):1301-1308.e1. doi: 10.1016/j.jvs.2021.03.039. Epub 2021 Apr 19.
2
Outcomes of antegrade and retrograde open mesenteric bypass for acute mesenteric ischemia.顺行和逆行开放肠系膜旁路术治疗急性肠系膜缺血的结果。
J Vasc Surg. 2019 Jan;69(1):129-140. doi: 10.1016/j.jvs.2018.04.063. Epub 2018 Jun 29.
3
Comparative outcomes of open mesenteric bypass after a failed endovascular or open mesenteric revascularization for chronic mesenteric ischemia.慢性肠系膜缺血患者行血管内或开放肠系膜血运重建失败后行开放肠系膜旁路手术的疗效比较。
J Vasc Surg. 2024 Aug;80(2):413-421.e3. doi: 10.1016/j.jvs.2024.03.028. Epub 2024 Mar 27.
4
Multicenter study of retrograde open mesenteric artery stenting through laparotomy for treatment of acute and chronic mesenteric ischemia.经剖腹手术逆行开放肠系膜动脉支架置入术治疗急性和慢性肠系膜缺血的多中心研究。
J Vasc Surg. 2018 Aug;68(2):470-480.e1. doi: 10.1016/j.jvs.2017.11.086. Epub 2018 Mar 13.
5
Direct Retrograde Bypass is Preferable to Antegrade Bypass for Open Mesenteric Revascularization.对于开放性肠系膜血管重建术,直接逆行旁路术优于顺行旁路术。
Ann Vasc Surg. 2020 Jul;66:263-271. doi: 10.1016/j.avsg.2020.01.019. Epub 2020 Jan 10.
6
Revascularization of the superior mesenteric artery alone for treatment of chronic mesenteric ischemia.单纯肠系膜上动脉血运重建术治疗慢性肠系膜缺血。
Wien Klin Wochenschr. 2016 Feb;128(3-4):109-13. doi: 10.1007/s00508-015-0897-1. Epub 2015 Dec 9.
7
Chronic mesenteric ischemia: when and how to intervene on patients with celiac/SMA stenosis.慢性肠系膜缺血:何时以及如何对患有腹腔干/肠系膜上动脉狭窄的患者进行干预。
J Cardiovasc Surg (Torino). 2017 Apr;58(2):321-328. doi: 10.23736/S0021-9509.16.09829-3. Epub 2016 Dec 19.
8
Chronic mesenteric ischemia outcome analysis and predictors of endovascular failure.慢性肠系膜缺血的结局分析及血管内治疗失败的预测因素
J Vasc Surg. 2016 Jun;63(6):1582-7. doi: 10.1016/j.jvs.2016.02.051. Epub 2016 Apr 9.
9
Contemporary management of acute and chronic mesenteric ischemia: 10-year experience from a multihospital healthcare system.当代急性和慢性肠系膜缺血的治疗:多医院医疗系统 10 年经验。
J Vasc Surg. 2022 May;75(5):1624-1633.e8. doi: 10.1016/j.jvs.2021.11.040. Epub 2021 Nov 14.
10
Midterm results after covered stenting of the superior mesenteric artery.经覆膜支架治疗的肠系膜上动脉中期结果。
J Vasc Surg. 2021 Sep;74(3):902-909.e3. doi: 10.1016/j.jvs.2021.02.038. Epub 2021 Mar 6.

引用本文的文献

1
Characterization of multiple organ failure after ruptured abdominal aortic aneurysm repair.破裂性腹主动脉瘤修复术后多器官衰竭的特征。
J Vasc Surg. 2023 Oct;78(4):945-953.e3. doi: 10.1016/j.jvs.2023.06.011. Epub 2023 Jun 27.
2
Chronic mesenteric ischemia-induced intestinal dysbiosis resolved after revascularization.慢性肠系膜缺血引起的肠道菌群失调在血管重建后得到缓解。
J Vasc Surg Cases Innov Tech. 2022 Dec 23;9(2):101084. doi: 10.1016/j.jvscit.2022.101084. eCollection 2023 Jun.